Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...

The Immune Cell Engager Partnering & Investment Summit is here. As part of the game-changing Partnering & Investment Series, ...

Back for its second year, the ADC Partnering & Investment Summit unites 100+ top ADC companies, pharma leaders, and investors ...